[Clinical experiences with a new spasmoanalgesic agent in double-blind test].
D000632:Aminopyrine / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D011431:Dextropropoxyphene / Q000008:administration & dosage; D004158:Diphenylacetic Acids / Q000008:administration & dosage; D000431:Ethanol / Q000008:administration & dosage; D006801:Humans; D010146:Pain / Q000188:drug therapy*; D010276:Parasympatholytics / Q000008:administration & dosage*; D010879:Piperazines / Q000008:administration & dosage; D011183:Postoperative Complications / Q000188:drug therapy; D013035:Spasm / Q000188:drug therapy*; D013488:Suppositories; D013607:Tablets; D014966:Xanthenes / Q000008:administration & dosage
D004158:Diphenylacetic Acids; D010276:Parasympatholytics; D010879:Piperazines; D013488:Suppositories; D013607:Tablets; D014966:Xanthenes; D000632:Aminopyrine; D000431:Ethanol; D011431:Dextropropoxyphene
Klinische Erfahrungen mit einem neuen Spasmoanalgetikum im Koppelblindversuch.